Follow @UKGovscan on X for updates and inquiries

UKGovscanBETA

BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.

Loading contract…

Hepatitis C Medicines | UKGovscan

AWARDEDProcurement notice · The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Ref ocds-r6ebe6-0000574398

Hepatitis C Medicines

Save Track Track buyer

Contract Value

£45,000,000

Suppliers

AbbVie Ltd · Gilead Sciences Ltd +1 more

Procurement

Open procedure

Source

Public Contracts Scotland

View original notice

The notice does not give contract dates.

Description

This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland.

Pricing was requested under two (2) pricing models as outlined below:

Lot 1 - Treatment Cost per Medicine

Lot 2 - Treatment Spend Cap

Buyer

Organisation: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Buyer ID: org-1
Local Authority Code: –
Address: Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, EH12 9EB
Website: http://www.nhsscotlandprocurement.scot.nhs.uk/

Suppliers

Supplier	Identifier	Award Value	Lots Won	Cross-References
AbbVie Ltd	08004972	-	2 lots Treatment Cost per Medicine · Treatment Spend Cap	LOBBYIST Policy Connect Limited (15 quarters) Portland PR Limited (3 quarters) WA Communications Ltd (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter)
Gilead Sciences Ltd	02543818	-	2 lots Treatment Cost per Medicine · Treatment Spend Cap	LOBBYIST Ovid Consulting Ltd (4 quarters) Portland PR Limited (1 quarter) WA Communications Ltd (1 quarter)
MSD	-	-	1 lot Treatment Cost per Medicine	-

Lots

This procurement was divided into 2 lots, each awarded separately. 5 bids were received in total.

Lots

Initial Term Value

£32,583,333

Bids Received

Bids per Lot

2–3

Lot	Value	Bids Received	Awarded To	Status
Lot 2 Treatment Spend Cap 660 days (≈1.8 yrs)	£22,808,333 initial term	2	AbbVie Ltd Gilead Sciences Ltd	complete
Lot 1 Treatment Cost per Medicine 660 days (≈1.8 yrs)	£9,775,000 initial term	3	AbbVie Ltd Gilead Sciences Ltd MSD	complete

Award criteria

Weightings from the notice, applied to every lot.

Treatment Duration2.5%

Price95%

Government spending data: These suppliers have received £168,671,936 in 1,018 payments (over £25k) from Department of Health and Social Care, Manchester University NHS Foundation Trust, The Christie NHS Foundation Trust, Plymouth Hospitals NHS Trust, Guy's and St Thomas' NHS FT and 7 more public bodies (2018-09-19 to 2026-03-31).

Key Dates

Published: 4 June 2019
Tender Open: -
Tender Deadline: 15 April 2019
Award Date: -
Contract Signed: 8 May 2019
Contract Start: -
Contract End: -
Extension option: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s).

Procurement Details

Method: Open — any supplier may bid
Method Details: Open procedure
Route to market: Framework set up
Main category: Goods
Category: –
Delivery location: UKM
Open under: WTO Government Procurement Agreement
Buyer Reference: NP49119
Legal Basis: Public Contracts Regulations 2015 (EU Directive 2014/24)
CPV Codes: 33600000

Tender Documents

Hepatitis C Medicines → — Contract notice
Hepatitis C Medicines → — Award notice

Buyer contact

Buyer website: https://www.publictendersscotland.publiccontractsscotland.gov.uk

Published by the buyer on this notice. Check the original notice — details change and are not updated here.

Loading contract…

AWARDEDProcurement notice · The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")Ref ocds-r6ebe6-0000574398

Hepatitis C Medicines

Save Track Track buyer

Contract Value

£45,000,000

Suppliers

AbbVie Ltd · Gilead Sciences Ltd +1 more

Procurement

Open procedure

Source

Public Contracts Scotland

View original notice

The notice does not give contract dates.

Description

This procurement is for the supply of medicines used in the treatment of Hepatitis C to NHS Scotland.

Pricing was requested under two (2) pricing models as outlined below:

Lot 1 - Treatment Cost per Medicine

Lot 2 - Treatment Spend Cap

Buyer

Organisation: The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
Buyer ID: org-1
Local Authority Code: –
Address: Gyle Square (NSS Head Office), 1 South Gyle Crescent, Edinburgh, EH12 9EB
Website: http://www.nhsscotlandprocurement.scot.nhs.uk/

Suppliers

Supplier	Identifier	Award Value	Lots Won	Cross-References
AbbVie Ltd	08004972	-	2 lots Treatment Cost per Medicine · Treatment Spend Cap	LOBBYIST Policy Connect Limited (15 quarters) Portland PR Limited (3 quarters) WA Communications Ltd (3 quarters) Incisive Health Ltd (1 quarter) Political Lobbying & Media Relations Limited (1 quarter)
Gilead Sciences Ltd	02543818	-	2 lots Treatment Cost per Medicine · Treatment Spend Cap	LOBBYIST Ovid Consulting Ltd (4 quarters) Portland PR Limited (1 quarter) WA Communications Ltd (1 quarter)
MSD	-	-	1 lot Treatment Cost per Medicine	-

Lots

This procurement was divided into 2 lots, each awarded separately. 5 bids were received in total.

Lots

Initial Term Value

£32,583,333

Bids Received

Bids per Lot

2–3

Lot	Value	Bids Received	Awarded To	Status
Lot 2 Treatment Spend Cap 660 days (≈1.8 yrs)	£22,808,333 initial term	2	AbbVie Ltd Gilead Sciences Ltd	complete
Lot 1 Treatment Cost per Medicine 660 days (≈1.8 yrs)	£9,775,000 initial term	3	AbbVie Ltd Gilead Sciences Ltd MSD	complete

Award criteria

Weightings from the notice, applied to every lot.

Treatment Duration2.5%

Price95%

Key Dates

Published: 4 June 2019
Tender Open: -
Tender Deadline: 15 April 2019
Award Date: -
Contract Signed: 8 May 2019
Contract Start: -
Contract End: -
Extension option: The Authority is entitled at its sole discretion to extend the Framework Agreement for up to a maximum of twelve (12) months by giving a minimum of three (3) months written notice of such extension(s).

Procurement Details

Method: Open — any supplier may bid
Method Details: Open procedure
Route to market: Framework set up
Main category: Goods
Category: –
Delivery location: UKM
Open under: WTO Government Procurement Agreement
Buyer Reference: NP49119
Legal Basis: Public Contracts Regulations 2015 (EU Directive 2014/24)
CPV Codes: 33600000

Tender Documents

Hepatitis C Medicines → — Contract notice
Hepatitis C Medicines → — Award notice

Buyer contact

Buyer website: https://www.publictendersscotland.publiccontractsscotland.gov.uk

Published by the buyer on this notice. Check the original notice — details change and are not updated here.